AWH
Aspira Women's Health Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.08
−15.90%Year over year
Reported trailing growth
- Revenue
- +4.2%
- EBITDA
- +29.6%
- EBIT
- +40.8%
- EPS
- —
- Free cash flow
- +58.4%
- Operating cash flow
- +58.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +10.5%
- EBITDA
- +1.8%
- EBIT
- +13.7%
- Net income
- +21.5%
- EPS
- +48.6%
- Free cash flow
- +23.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2025